Chemoprotective functions of glutathione S-transferases in cell lines induced to express specific isozymes by stable transfection

Chemico-Biological Interactions

Volumn 111-112, Issue , 1998, Pages 389-407

  Townsend, Alan J ^a   Fields, Wanda R ^a,b   Haynes, Robin L ^a   Doss, Amanda J ^a   Li, Ying ^a,c   Doehmer, Johannes ^d   Morrow, Charles S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b RJR Research and Development   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Carcinogenesis; Chemoprevention; Cytotoxicity; Glutathione S transferase; Mutagenesis; Transfection

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; GLUTATHIONE TRANSFERASE; ISOENZYME;

ARTICLE; CARCINOGENESIS; CELL PROTECTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOTOXICITY; DNA ALKYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MUTAGENESIS; PROTEIN EXPRESSION; SISTER CHROMATID EXCHANGE;

4-NITROQUINOLINE-1-OXIDE; 7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ALKYLATION; ANIMALS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; GENE EXPRESSION; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; METABOLIC DETOXICATION, DRUG; MICE; NEOPLASMS; RATS; TRANSFECTION;

MINK CELL FOCUS-FORMING VIRUS; MURINAE;

EID: 4244020405     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(97)00175-0     Document Type: Article

References (42)

1. Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat. Res. 202:1988;343-631. Review.
2. Igwe O.J. Biologically active intermediates generated by the reduced glutathione conjugation pathway. Toxicological implications. Biochem. Pharmacol. 35:1986;2987-2994.
3. Guengerich F.P., Peterson L.A., Cmarik J.L., Koga N., Inskeep P.B. Activation of dihaloalkanes by glutathione conjugation and formation of DNA adducts. Environ. Health Perspect. 76:1987;15-18.
4. Doehmer J., Dogra S., Friedberg T., Monier S., Adesnik M., Glatt H., Oesch F. Stable expression of rat cytochrome P-450IIB1 cDNA in Chinese hamster cells (V79) and metabolic activation of aflatoxin B1. Proc. Natl. Acad. Sci. USA. 85:1988;5769-5773.
5. Dogra S., Doehmer J., Glatt H., Molders H., Siegert P., Freidberg T., Seidel A., Oesch F. Stable expression of rat cytochrome P-4501A1 cDNA in V79 chinese hamster cells and their use in mutagenicity testing. Mol. Pharmacol. 37:1990;608-613.
6. Moscow J.A., Townsend A.J., Cowan K.H. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST1 gene and its effect on sensitivity to toxins. Mol. Pharmacol. 36:1989;22-28.
7. Townsend A.J., Tu C.P., Cowan K.H. Expression of human mu or α class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: Effect on cellular sensitivity to cytotoxic agents. Mol. Pharmacol. 41:1992;230-236.
8. Fields W.R., Li Y., Townsend A.J. Protection by transfected glutathione S-transferase isozymes against carcinogen-induced alkylation of cellular macromolecules in human MCF-7 cells. Carcinogenesis. 15:1994;1155-1160.
9. Bunting K.D., Townsend A.J. De novo expression of transfected human class 1 aldehyde dehydrogenase (ALDH) causes resistance to oxazaphosphorine anti-cancer alkylating agents in hamster V79 cell lines. J. Biol. Chem. 271:1996;11884-11890.
10. Moscow J.A., Fairchild C.R., Madden M.J., Ransom D.T., Wieand H.S., O'Brien E.E., Poplack D.G., Cossman J., Myers C.E., Cowan K.H. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 49:1989;1422-1428.
11. Rhoads D.M., Zarlengo R.P., Tu C.P. The basic glutathione S-transferases from human livers are products of separate genes. Biochem. Biophys. Res. Commun. 145:1987;474-481.
12. DeJong J.L., Chang C.-M., Whang-Peng J., Knutsen T., Tu C.-P.D. The human liver glutathione S-transferase gene superfamily: expression and chromosome mapping of an Hb subunit cDNA. Nucleic Acids Res. 16:1988;8541-8554.
13. Buetler T.M., Eaton D.L. Complementary DNA cloning, messenger RNA expression and induction of α-class glutathione S-transferases in mouse tissues. Cancer Res. 52:1992;314-318.
14. Townsend A.J., Goldsmith M.E., Pickett C.B., Cowan K.H. Isolation, characterization and expression in Escherichia coli of two murine mu class glutathione S-transferase cDNAs homologous to the rat subunits 3 (Yb1) and 4 (Yb2). J. Biol. Chem. 264:1989;21582-21590.
15. Schneider E., Horton J.K., Yang C.H., Nakagawa M., Cowan K.H. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 line selected for etoposide resistance. Cancer Res. 54:1994;152-158.
16. K.W. Kohn, R.A.G. Ewig, L.C. Erickson, L.A. Zwelling, Measurement of strand breaks and cross-links by alkaline elution, in: Friedburg, Errol C. and Hanawalt, Philip (Eds.), DNA Repair, A Laboratory Manual, Marcel Dekker, New York, 1979, pp. 379-401.
17. Cesarone C.F., Bolognesi C., Santi L. Improved microfluorometric DNA determination in biological material using 33258 Hoecht. Anal. Biochem. 100:1979;188-197.
18. Swedmark S., Romert L., Morgenstern R., Jenssen D. Studies on glutathione transferases belonging to class pi in cell lines with different capacities for conjugating (+)-7β, 8α-dihydroxy-9α,10α-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Carcinogenesis. 13:1992;1719-1723.
19. Quinn B.A., Crane T.L., Kocal T.E., Best S.J., Cameron R.G., Rushmore T.H., Farber E., Hayes M.A. Protective activity of different hepatic cytosolic glutathione S-transferases against DNA-binding metabolites of aflatoxin B1. Toxicol. Appl. Pharmacol. 105:1990;351-363.
20. Ramsdell H.S., Eaton D.L. Mouse liver glutathione S-transferase isoenzyme activity toward aflatoxin B1-8,9-epoxide and benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide. Toxicol. Appl. Pharmacol. 105:1990;216-225.
21. Loveday K.S., Anderson B.E., Resnick M.A., Zeiger E. Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro. V: Results with 46 chemicals. Environ. Mol. Mutagen. 16:1990;272-303.
22. Hayes J.D., Judah D.J., McLellan L.I., Neal G.E. Contribution of the glutathione S-transferases to the mechanisms of resistance to aflatoxin B1. Pharmacol. Ther. 50:1991;443-472.
23. Buetler T.M., Bammler T.K., Hayes J.D., Eaton D.L. Oltipraz-mediated changes in aflatoxin B1 biotransformation in rat liver: implications for human chemointervention. Cancer Res. 56:1996;2306-2313.
24. Borroz K.I., Ramsdell H.S., Eaton D.L. Mouse strain differences in glutathione S-transferase activity and aflatoxin B1 biotransformation. Toxicol. Lett. 58:1991;97-105.
25. Mannervik B., Danielson U.H. Glutathione transferases - structure and catalytic activity. CRC Crit. Rev. Biochem. 23:1988;283-337. Review.
26. Hayes J.D., Pulford D.J. The glutathione supergene S-Transferase family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30:1995;445-600.
27. Robertson I.G., Guthenberg C., Mannervik B., Jernstrom B. Differences in stereoselectivity and catalytic efficiency of three human glutathione transferases in the conjugation of glutathione with 7β,8α-dihydroxy-9α,10α-oxy-7,8,9,10-tetrahydrobenzo(a) pyrene. Cancer Res. 46:1986;2220-2224.
28. Wattenberg L.W. Prevention - therapy - basic science and the resolution of the cancer problem. Cancer Res. 53:1993;5890-5896. Review.
29. Langouet S., Coles B., Morel F., Becquemont L., Beaune P., Guengerich F.P., Ketterer B., Guillouzo A. Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture. Cancer Res. 55:1995;5574-5579.
30. Helzlsouer K.J., Kensler T.W. Cancer chemoprotection by oltipraz: experimental and clinical considerations. Prev. Med. 22:1993;783-795. Review.
31. Kensler T., Styczynski P., Groopman J., Helzlsouer K., Curphey T., Maxuitenko Y., Roebuck B.D. Mechanisms of chemoprotection by oltipraz. J Cell. Biochem. 161:1992;167-172.
32. Prochaska H.J., De L.M., Talalay P. On the mechanisms of induction of cancer-protective enzymes: a unifying proposal. Proc. Natl. Acad. Sci. USA. 82:1985;8232-8236.
33. Talalay P., Fahey J.W., Holtzclaw W.D., Prestera T., Zhang Y.S. Chemoprotection against cancer by phase 2 enzyme induction. Toxicol. Lett. 83:1995;173-179.
34. Kensler T.W., Davidson N.E., Groopman J.D., Roebuck B.D., Prochaska H.J., Talalay P. Chemoprotection by inducers of electrophile detoxication enzymes. Basic Life Sci. 61:1993;127-136. Review.
35. Kensler T.W., Egner P.A., Davidson N.E., Roebuck B.D., Pikul A., Groopman J.D. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. Cancer Res. 46:1986;3924-3931.
36. Sparnins V.L., Barany G., Wattenberg L.W. Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis. 9:1988;131-134.
37. Davidson N.E., Egner P.A., Kensler T.W. Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver. Cancer Res. 50:1990;2251-2255.
38. Mannervik B. Evolution of glutathione transferases and related enzymes for the protection of cells against electrophiles. Biochem. Soc. Trans. 24:1996;878-880.
39. C.S. Morrow, S. Diah, P. Smitherman, E. Schneider, A.J. Townsend, Multidrug resistance protein and glutathione S-transferase P1-1 act in synergy to confer protection from 4-nitroquinoline 1-oxide toxicity. Carcinogenesis (1997, in press).
40. Ramsdell H.S., Eaton D.L. Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation. Cancer Res. 50:1990;615-620.
41. Hayes J.D., Judah D.J., McLellan L.I., Kerr L.A., Peacock S.D., Neal G.E. Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel α-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide. Biochem. J. 279:1991;385-398.
42. Loe D.W., Stewart R.K., Massey T.E., Deeley R.G., Cole S. ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene. Mol. Pharmacol. 51:1997;1034-1041.